Immunotherapy, targeted treatments, HIPEC, and new delivery options ...

Emerging immunotherapies and targeted therapies take aim at recently identified biomarkers ...

This years 2026 ASCO Gastrointestinal Cancers Symposium was packed with practice-shaping data across colorectal and upper ...

Stomach cancer, also known as gastric cancer, begins in the cells that line the stomach. The vast majority of stomach cancers are the adenocarcinoma type, which affects the glandular mucus-producing ...

Frequently prescribed medications for gastric acidity, such as proton pump inhibitors, are the subject of recurring discussions about their long-term safety. Previous studies had indeed cast ...

Proton pump inhibitors are among the most commonly prescribed medications worldwide, but concerns about a possible link to ...

Can what you eat help you avoid getting stomach cancer? "Most cases of stomach cancer happen sporadically and are purely a ...

Scotland has approved its first CLDN18.2-targeted therapy for advanced gastric and GEJ cancer, expanding options for patients ...

Metastatic stomach cancer is cancer that has spread beyond your stomach to distant tissues. Treatment generally focuses on extending your life and reducing symptoms. Metastatic stomach cancer is also ...

Stomach cancer is challenging to detect early due to vague symptoms, often diagnosed at advanced stages. Diagnosis involves endoscopy, imaging, laparoscopy, and molecular testing for markers like HER2 ...

If you naturally associate stomach cancer with brutally painful stomachaches, you're not the only one. And yet, stomachaches are not typically a sign of this rare form of cancer at any point in its ...

Long-term use of common anti-acid medications, known as proton pump inhibitors (PPIs), may not increase the risk of stomach ...